Darren Hargrave
- Genetics top 0.1%
- Neurology top 0.5%
- Molecular Biology top 5%
- Epidemiology top 5%
- Oncology top 5%
- Co-authors
- Éric BouffetUte BartelsChris JonesDorine A. BaxLara PerrymanUri TaboriBirgit GeoergerRui Manuel Reis
- Topics
- Glioma Diagnosis and Treatment (112 papers)Neuroblastoma Research and Treatments (55 papers)Meningioma and schwannoma management (23 papers)
- Cited by
- GeneticsNeurologyCancer Research
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Darren Hargrave
172 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Genetics 3.3k
- Neurology 2.1k
- Molecular Biology 1.8k
- Epidemiology 852
- Oncology 779
Countries citing papers authored by Darren Hargrave
This map shows the geographic impact of Darren Hargrave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren Hargrave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren Hargrave more than expected).
Fields of papers citing papers by Darren Hargrave
This network shows the impact of papers produced by Darren Hargrave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren Hargrave. The network helps show where Darren Hargrave may publish in the future.
Co-authorship network of co-authors of Darren Hargrave
This figure shows the co-authorship network connecting the top 25 collaborators of Darren Hargrave. A scholar is included among the top collaborators of Darren Hargrave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren Hargrave. Darren Hargrave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutationsbreakdown → | 125 |
| 6 | 11 | |
| 7 | 11 | |
| 8 | 13 | |
| 9 | 9 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | A 7-Year Update Report of a National, Interdisciplinary Endeavour to Improve Outcomes for Children and Young People Under 19 Years of Age with Hypothalamic Pituitary Axis Tumours (HPAT) Using Multi-site Video Conferencing | 2 |
| 13 | 23 | |
| 14 | 39 | |
| 15 | 226 | |
| 16 | A PHASE 3, MULTICENTER, OPEN-LABEL, RANDOMIZED, CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF ORAL SONIDEGIB (LDE225) VERSUS TEMOZOLOMIDE IN PATIENTS WITH HEDGEHOG PATHWAY-ACTIVATED RELAPSED MEDULLOBLASTOMA | 5 |
| 17 | 143 | |
| 18 | 41 | |
| 19 | 110 | |
| 20 | 71 |
About Darren Hargrave
Darren Hargrave is a scholar working on Genetics, Neurology and Pediatrics, Perinatology and Child Health, having authored 187 papers that have together received 5.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (112 papers), Neuroblastoma Research and Treatments (55 papers) and Meningioma and schwannoma management (23 papers). The work is most often cited by research in Genetics (3.3k citations), Neurology (2.1k citations) and Cancer Research (687 citations). Darren Hargrave has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Éric Bouffet, Ute Bartels, Chris Jones, Dorine A. Bax, Lara Perryman, Uri Tabori, Birgit Geoerger, Rui Manuel Reis, Alberto Broniscer and Isabelle Aerts. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.